Zhuhai Tongsheng Investment

Zhuhai Tongsheng Investment Partnership (Limited Partnership) is a specialized healthcare investment and holding vehicle based in Zhuhai, China. The entity gained significant industry prominence in early 2024 when Mindray (Shenzhen Mindray Bio-Medical Electronics) acquired control of the partnership as part of a $927 million strategic deal to take over APT Medical (Huitai Medical). Historically, the partnership served as an investment arm for Shenzhen Hepalink Pharmaceutical Group, facilitating major holdings in international biotechnology firms such as Resverlogix. It currently operates as a core holding entity for Mindray’s expanding cardiovascular and electrophysiology business segments, overseeing a portfolio that includes advanced medical device manufacturing and clinical-stage pharmaceutical assets.